Patient Perspectives Associated with Intended Duration of Buprenorphine Maintenance Therapy-Reference-Cited by-同舟云学术

Patient Perspectives Associated with Intended Duration of Buprenorphine Maintenance Therapy

Published:2015-09 Issue: Volume:56 Page:48-53
ISSN:0740-5472
Container-title:Journal of Substance Abuse Treatment
language:en
Short-container-title:Journal of Substance Abuse Treatment

Author:

Bentzley Brandon S.,Barth Kelly S.,Back Sudie E.,Aronson Garrett^ORCID,Book Sarah W.

Funder

National Institutes of Health

Publisher

Elsevier BV

Subject

Psychiatry and Mental health,Clinical Psychology,Medicine (miscellaneous),Pshychiatric Mental Health

Reference41 articles.

1. Psychosocial combined with agonist maintenance treatments versus agonist maintenance treatments alone for treatment of opioid dependence;Amato;Cochrane Database of Systematic Reviews (Online),2011

2. Perceived relapse risk and desire for medication assisted treatment among persons seeking inpatient opiate detoxification;Bailey;Journal of Substance Abuse Treatment,2013

3. Patient satisfaction with primary care office-based buprenorphine/naloxone treatment;Barry;Journal of General Internal Medicine,2007

4. Pain and motives for use among non-treatment seeking individuals with prescription opioid dependence;Barth;American Journal on Addictions,2013

5. The effect of methadone prescribing in a clinic setting on the criminal activity of drug users;Bates;Scottish Medical Journal,1996

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New Challenges and Opportunities for Opioid Agonist Treatment Access and Retention: A Scoping Review;Journal of Drug Issues;2024-08-02

2. Assessing predictors of adequate individual buprenorphine maintenance dosage for the treatment of opioid use disorder: Listening to the patient;International Journal of Drug Policy;2024-08

3. A mixed-methods review and meta-synthesis of fears of recurrence and progression in people with mental health conditions;Clinical Psychology Review;2023-11

4. Buprenorphine use and courses of care for opioid use disorder treatment within the Veterans Health Administration;Drug and Alcohol Dependence;2023-07

5. Integrating cognitive bias modification for pain and opioid cues into medication for opioid use disorder clinical care: Feasibility, acceptability, and preliminary results;Drug and Alcohol Dependence;2023-05